The nuclear protein HMGB1 (high mobility group box 1) is secreted by monocytesmacrophages in response to inflammatory stimuli and serves as a danger-associated molecular pattern. Acetylation and phosphorylation of HMGB1 are implicated in the regulation of its nucleocytoplasmic translocation for secretion, although inflammatory stimuli are also known to induce H 2 O 2 production. showed a higher affinity for the nuclear exportin CRM1 compared with the reduced form.
Introduction
High mobility group box 1 (HMGB1) is a nonhistone nuclear protein that functions as a DNA chaperone during chromatin reorganization and transcriptional regulation (Lee et al, 2014; Lotze & Tracey, 2005) and which shuttles between the nucleus and cytoplasm of mammalian cells. Exit of HMGB1 from the nucleus occurs by both passive diffusion and an actively controlled pathway mediated by chromosome region maintenance protein 1 (CRM1), with import of the protein back into the nucleus also being actively controlled (Kang et al, 2014) .
The trafficking of HMGB1 between the nucleus and cytoplasm has been thought to be regulated by protein acetylation and phosphorylation (Bonaldi et al, 2003; Youn & Shin, 2006) . When HMGB1 is hypoacetylated or hypophosphorylated, the rate of nuclear import exceeds that of export, resulting in a predominantly nuclear localization. When HMGB1 is acetylated or phosphorylated at its nuclear localization signal (NLS) sequences in the nucleus, however, it is still able to exit the nucleus but reimport is inhibited, resulting in its accumulation in the cytoplasm. HMGB1 is passively released from cells via pyroptosis and necroptosis, but it is also actively secreted from monocytes and macrophages in response to exposure of the cells to inflammatory stimuli such as lipopolysaccharide (LPS) and tumor necrosis factor α (TNFα). HMGB1 does not contain a leader sequence, with such secretion occurring through a vesicle-mediated pathway (Gardella et al, 2002) . Secreted HMGB1 acts as a damage-associated molecular pattern (DAMP) molecule to signal danger to surrounding cells, triggers inflammation, and activates innate and adaptive immunity by binding to a plethora of cell surface receptors including Toll-like receptor 2 (TLR2), TLR4, TLR9, receptor for advanced glycation end products (RAGE), and C-X-C chemokine receptor 4 (CXCR4). HMGB1 also interacts with the pathogen-associated molecular pattern (PAMP) molecules LPS and lipoteichoic acid (Kwak et al, 2015; Youn et al, 2008) as well as with endogenous C-X-C motif chemokine 12 (CXCL12) , interleukin-1 (Sha et al, 2008) , and nucleosomes (Tian et al, 2007) to augment inflammation. Furthermore, HMGB1 mediates autophagosome formation by binding to beclin-1 (Tang et al, 2010) , and it inhibits polyglutamine aggregate formation in the cytoplasm through a chaperone-like function (Min et al, 2013) .
HMGB1 contains three conserved cysteine residues: Cys 23 , Cys 45 , and Cys 106 . The redox state of these cysteines gives rise to at least three forms of HMGB1 that are designated "reduced HMGB1" (all three cysteine residues in the thiol state), "disulphide HMGB1" (an intramolecular disulphide bond between Cys 23 and Cys 45 ; Cys 106 in the thiol state), and "sulfonic HMGB1" (all three cysteines in the hyperoxidized sulfonic acid state). The specific functions of HMGB1 have recently been shown to be dependent on the redox state of its cysteines , with reduced HMGB1 forming a complex with CXCL12 to promote the migration of immune cells , disulphide HMGB1 (but not reduced HMGB1) interacting with a TLR4 adaptor protein to activate TLR4 and induce proinflammatory responses (Yang et al, 2010) , and sulfonic HMGB1 manifesting neither cytokine-nor chemokine-like function (Kazama et al, 2008) . In addition, displacement of histone H1 from DNA is promoted by reduced HMGB1, whereas the binding of histone H1 to chromatin is dependent on HMGB1 oxidation (Kohlstaedt et al, 1987; Polanska et al, 2014) .
The redox state of HMGB1 in the nucleus thus plays an important role in transcriptional regulation.
HMGB1 present inside cells (nucleus and cytoplasm) is predominantly in the fully reduced state, whereas the presence of disulphide HMGB1 in serum has been associated with inflammation-related pathologies Liesz et al, 2015; Lundback et al, 2016; Palmblad et al, 2015) . However, fundamental issues regarding the oxidation of Cys 23 and Cys 45 of HMGB1-including the mechanism by which such oxidation occurs in response to inflammatory signals, the subcellular compartment where the oxidation occurs, and the effect of oxidation on HMGB1 secretion-have remained unclear.
Hydrogen peroxide (H 2 O 2 ) is produced by cells in response to various extracellular stimuli and propagates intracellular signaling by oxidizing protein thiols .
Cells are also equipped with H 2 O 2 -eliminating enzymes such as catalase, glutathione peroxidase, and peroxiredoxin (Prx). The Prx family of peroxidases reduces H 2 O 2 or alkyl peroxide, with the thiol of a conserved cysteine residue (the peroxidatic Cys, or C P -SH)
serving as the site of oxidation by peroxides. In addition to C P -SH located in the NH 2 -terminal region of the molecule, most Prx enzymes contain an additional conserved cysteine (the resolving Cys, or C R -SH) in the COOH-terminal region. Mammalian cells express six isoforms of Prx (PrxI to PrxVI) that differ in their subcellular localization (Wood et al, 2003) .
PrxI and PrxII are thus localized in the cytosol and nucleus, whereas PrxIII and PrxIV are restricted to mitochondria and the endoplasmic reticulum, respectively. During the catalytic cycle of Prx enzymes, C P -SH is first oxidized by H 2 O 2 to sulfenic acid (C P -SOH), which then reacts with C R -SH to form a disulphide that is subsequently reduced by an appropriate electron donor to complete the cycle.
Peroxiredoxins are abundant proteins, with PrxI and PrxII together constituting a total of 0.2% to 1% of soluble protein in cultured mammalian cells (Chae et al, 1999) . In addition,
Prxs possess an active-site pocket that gives rise to a high-affinity (submicromolar dissociation constant) peroxide binding site that is lacking in catalase and glutathione peroxidase (Rhee & Kil, 2017) . This pocket is arranged so as to elicit rapid oxidation of C P - (Kakihana et al, 2013) , apoptosis signalregulating kinase 1 (Zhang et al, 2015) , mitogen-activated protein kinase (MAPK) (Latimer & Veal, 2016; Turner-Ivey et al, 2013) , and the transcription factor STAT3 (Sobotta et al, 2015) .
We now show that disulphide formation between Cys 23 and Cys 45 of HMGB1 is mediated by PrxI and PrxII in the nucleus and is essential for the nucleocytoplasmic translocation and secretion of HMGB1. Inflammatory stimuli such as LPS and TNFα as well as chemicals including phorbol 12-myristate 13-acetate (PMA) and trichostatin A (TSA) have been shown to induce the phosphorylation or acetylation of HMGB1 at its NLS sequences and thereby to promote its nucleocytoplasmic translocation for secretion (Bonaldi et al, 2003; Youn & Shin, 2006 
Results

HMGB1 oxidation mediated by PrxI and PrxII in the nucleus
LPS has been shown to induce HMGB1 secretion by promoting the acetylation of HMGB1 in the nucleus. Ligation of TLR4 by LPS also elicits H 2 O 2 production through activation of NADPH oxidase 4 (Nox4) (Park et al, 2004) . To examine the effect of LPS on the formation of disulphide HMGB1, we stimulated mouse bone marrow-derived macrophages (BMDMs) with LPS and then subjected the nuclear fraction of these cells to nonreducing SDSpolyacrylamide gel electrophoresis (PAGE) followed by immunoblot analysis. Disulphide HMGB1 is more compact and thereby migrates faster in the electrophoretic gel compared with reduced HMGB1. HMGB1 in the nucleus of unstimulated cells existed predominantly in the fully reduced form (Fig 1A) . Stimulation with LPS, however, induced a time-dependent increase in the nuclear abundance of disulphide HMGB1 ( Fig 1A) .
We examined the possibility that nuclear (Fig 1B) . Nonreducing SDS-PAGE and immunoblot analysis revealed that LPS stimulation rapidly increased the abundance of the disulphide-linked dimeric forms of both PrxI and PrxII and that this effect preceded the oxidation of HMGB1 (Fig 1A) , suggesting that PrxI/II might indeed mediate the oxidation of HMGB1 in the nucleus. As expected, neither the higher-mobility form of HMGB1 nor dimeric PrxI/II was observed if dithiothreitol (DTT) was added to the nuclear extracts before electrophoresis ( Fig   1A) . Preparation of nuclear and cytosolic fractions from the cell lysates revealed that the coprecipitation was apparent with the former fraction but not the latter ( Fig 1E) . These results thus indicated that PrxI/II-mediated generation of disulphide HMGB1 occurs via formation of an intermolecular disulphide in the nucleus as proposed in Figure 1B We next evaluated the effect of the absence of PrxII on the formation of disulphide HMGB1 with the use of immortalized WT and PrxII-deficient (KO) MEFs. The protein kinase C (PKC) activator PMA is thought to stimulate HMGB1 secretion by inducing HMGB1 phosphorylation at serine residues located in the NLS sequences (Oh et al, 2009; Youn & Shin, 2006) . Like LPS, PMA also induces H 2 O 2 production by activating Nox enzymes (Karlsson et al, 2000) . Stimulation with LPS or PMA increased the abundance of disulphide HMGB1 in WT and PrxII KO MEFs, but this effect was markedly attenuated in the latter cells compared with the former for both stimulants (Fig 2A and B) . 
Oxidation to the disulphide form is necessary for nucleocytoplasmic translocation and secretion of HMGB1
We examined the relevance of the oxidation of HMGB1 to the disulphide form with regard to it had no such effect on EGFP-tagged HMGB1(C23S) or HMGB1(C45S), each of which forms a disulphide-linked complex with PrxI/II that cannot be further resolved to yield disulphide HMGB1 (Fig 3A and B) . Immunoblot analysis of culture supernatants revealed that LPS induced the secretion of endogenouse-HMGB1 in MEFs (Fig 3C) . The secreted protein was judged to be the disulphide form on the basis of the observation that its mobility on nonreducing SDS-PAGE was decreased by the addition of DTT to the culture supernatants ( Fig 3C) .
We also examined the nucleocytoplasmic transport toward secretion of Myc/EGFP- Like HMGB1 phosphorylation in PMA-treated cells, acetylation of the NLS sequences of HMGB1 in cells treated with the histone deacetylase inhibitor TSA promotes the nuclear transport of HMGB1 toward secretion (Bonaldi et al, 2003; Youn & Shin, 2006) .
Whereas PKC activation by PMA results in H 2 O 2 production through Nox activation (Karlsson et al, 2000) , TSA-induced acetylation of multiple mitochondrial proteins increases mitochondrial H 2 O 2 production . Binding of TNFα to its cognate receptor induces both acetylation and phosphorylation of the NLS sequences of HMGB1 and thereby promotes HMGB1 secretion (Bonaldi et al, 2003; Willenbrock et al, 2012; Youn & Shin, 2006 ). TNFα binding also induces H 2 O 2 production from multiple sources including mitochondria, Nox, and xanthine oxidase (Chen et al, 2008) . Treatment of MEFs or HEK293T cells with PMA, TSA, or TNFα stimulated HMGB1 release in a manner sensitive to inhibition by the antioxidant N-acetylcysteine (NAC) (Fig EV3E and F) , suggesting that oxidant production plays a key role in HMGB1 secretion. The Nox inhibitor diphenyleneiodonium (DPI) inhibited HMGB1 secretion induced by PMA but not that induced by TNFα (Fig EV3G) We next tested whether a phosphorylation-defective mutant (NLS1/2A, in which all six serines in the NLS sequences are replaced with alanine) of HMGB1 (Youn & Shin, 2006) is secreted in response to oxidative stimuli. Stimulation of HEK293T cells expressing Myc-HMGB1(WT) or Myc-HMGB1(NLS1/2A) with PMA or GOX revealed that secretion of the mutant protein did occur in response to each stimulant but at a level lower than that apparent for the WT protein, with secretion of both HMGB1(WT) and HMGB1(NLS1/2A) being greatly attenuated by NAC (Fig 3D and E) .
Collectively, these results indicated that intramolecular disulphide bond formation between Cys 23 and Cys 45 of HMGB1 is required for nucleocytoplasmic transport toward secretion in response to all the stimulants tested (LPS, H 2 O 2 , PMA, TSA, and TNFα).
Posttranslational modification such as phosphorylation and acetylation of the NLS sequences appears not to be required for HMGB1 translocation toward secretion but rather facilitates this process. PMA thus induced the secretion of an HMGB1 mutant without NLS phosphorylation sites, but the extent of this effect was less pronounced than that apparent with the WT protein. The observation that GOX-induced HMGB1 secretion was also partially inhibited by NLS mutation is likely related to the fact that PKC isoforms are activated by H 2 O 2 independently of diacylglycerol, the PKC activator mimicked by PMA (Konishi et al, 1997) .
Preferential binding of disulphide HMGB1 to CRM1
HMGB1 is sufficiently small to undergo passive diffusion through nuclear pores. Its nucleocytoplasmic translocation is also actively regulated by the nuclear exportin CRM1, to which HMGB1 binds directly (Bonaldi et al, 2003) . We examined the affinity of HMGB1 for CRM1 with the use of HEK293T cells transfected with expression vectors for CRM1 and Myc epitope-tagged WT, C23S, or C45S forms of HMGB1. Immunoprecipitation revealed that CRM1 binding to HMGB1(WT) was greatly increased by exposure of the cells to H 2 O 2 or GOX (Fig 4A) . In the treated cells, the apparent binding affinity of HMGB1 for CRM1 decreased in the rank order of WT > C23S > C45S (Fig 4A) . Similar results were obtained by PLA analysis of the proximity of the Myc epitope-tagged forms of HMGB1 and endogenous CRM1 (Fig 4B) . Together, these results thus indicated that the affinity of disulphide HMGB1
for CRM1 is greater than that of reduced HMGB1, likely explaining the increased rate of nucleocytoplasmic translocation of the disulphide form observed in the presence of various stimulants.
HMGB1 secretion from BMDMs is dependent on PrxI and PrxII
We have shown that HMGB1 oxidation to the disulphide form is mediated by PrxI and PrxII and that intramolecular disulphide formation is necessary for nucleocytoplasmic translocation and secretion of HMGB1 in nonimmune cell types such as HEK293T cells and MEFs. We therefore next investigated the role of PrxI and PrxII in HMGB1 secretion with the use of PrxI-or PrxII-deficient BMDMs (Fig EV4A) . HMGB1 secretion induced by LPS, PMA, TSA, TNF, H 2 O 2 , or GOX was attenuated in PrxI-or PrxII-deficient BMDMs compared with WT BMDMs (Fig 5; Fig EV4B and C) . As was the case for intramolecular disulphide formation in nonimmune cells (Fig 2A and B) , the suppression of HMGB1 secretion by PrxI or PrxII deficiency in BMDMs was partial. Partial inhibition of HMGB1 secretion induced by LPS or GOX was also apparent in PrxII KO MEFs compared with WT MEFs, whereas the extent of HMGB1 secretion was fully restored in the mutant cells by forced expression of PrxII (Fig EV4D and E) .
LPS-induced HMGB1 secretion is dependent on PrxI and PrxII in vivo
Finally, we examined the role of PrxI and PrxII in HMGB1 secretion in vivo. WT as well as PrxI-or PrxII-deficient mice were injected intraperitoneally with a sublethal dose (5 mg/kg) of LPS, and blood samples were collected at optimal times (1 and 16 h, respectively) for the measurement of TNF and HMGB1 concentrations in serum. LPS injection increased TNF levels to 22.0 ± 6.7 ng/ml in WT mice, to 15.7 ± 6.1 ng/ml in PrxI-deficient mice, and to 24.3 ± 6.9 ng/ml in PrxII-deficient mice (Fig 6A) , values that did not differ significantly from each other. In contrast, LPS increased HMGB1 levels in PrxI-or PrxII-deficient mice to 31.4 ± 13.6 and 43.6 ± 22.6 ng/ml, respectively, values that were significantly smaller than the corresponding value of 74.2 ± 14.7 ng/ml for WT mice (Fig 6B) .
Discussion
The nuclear protein HMGB1 passively leaks from necrotic and apoptotic cells of various types and is actively secreted from live monocytes-macrophages in response to stress signals (Kang et al, 2014) . HMGB1 in the extracellular milieu serves as a DAMP molecule.
Posttranslational modification such as acetylation of lysine residues or phosphorylation of serine residues located in the NLS sequences of HMGB1 has been proposed as the major mechanism for regulation of active nuclear exit of the protein (Bonaldi et al, 2003; Youn & Shin, 2006) . All stimulants of HMGB1 secretion tested in the present study (LPS, TNF, PMA, and TSA) are known to induce the intracellular production of H 2 O 2 at low levels, with oxidation of various proteinaceous cysteine residues by H 2 O 2 being an important mechanism of cell signalling (Poole & Nelson, 2008) . Necrotic and apoptotic cell death is also accompanied by H 2 O 2 production by mitochondria (Circu & Aw, 2010; Fiers et al, 1999) .
In the present study, we found that oxidation of Cys 23 HMGB1 is preferentially transported out of the nucleus as a result of its binding to the nuclear exportin CRM1 with higher affinity compared with that of reduced HMGB1-although, given that disulphide HMGB1 is more compact than the reduced form, preferential passive diffusion of disulphide HMGB1 cannot be excluded. It is also possible that, like acetylated HMGB1, disulphide HMGB1 may be less favoured for nuclear import and thus accumulates in the cytosol. Disulphide HMGB1 in the cytosol is packed into lysosomes through an as yet unknown mechanism and is then secreted. Our results show that HMGB1
that is actively secreted in response to LPS stimulation is present in the disulphide form, not the reduced form. Given that the cytosol contains various disulphide reductases such as thioredoxins and glutaredoxins that are capable of mediating the rapid reduction of disulphide HMGB1 to reduced HMGB1 (Hoppe et al, 2006) , the H 2 O 2 sensor and transducer function of PrxI and PrxII might also be needed in the cytosol to maintain HMGB1 in the disulphide form before it is packed into lysosomes.
Materials and Methods
Antibodies and chemicals
All antibodies for immunoblotting analysis were purchased from Abcam, Santa Cruz Biotechnology, Invitrogen Life Technologies, and AbFrontier Chemicals including LPS (L5293, Sigma), trichostatin A (T8552, Sigma), phorbol 12-myristate 13-acetate (P8139, Sigma), and N-ethyl maleimide (E3876, Sigma) were purchased from commercial venders.
Cell cultures
HEK293T, HEK293T-TLR4, and MEF cells were cultured in 10% FBS-Dulbecco's modified Eagle's medium (DMEM) supplemented with 100 U/mL penicillin, 100 g/mL streptomycin, and 2 mM L-glutamine at 37°C under 5% CO 2 . Primary mouse BMDM cells were prepared from male C57BL/6 WT, PrxI-, and PrxII-deficient mice (Bae et al, 2011; Lee et al, 2003) .
Briefly, bone marrow cells were obtained by flushing bone marrow of femurs and tibias after euthanasia and then maintained in complete DMEM medium containing 20% L929 culture supernatant for 7 days (Weischenfeldt & Porse, 2008) . BMDM cells were collected after incubation at 37C for 4 min with 0.25% trypsin-EDTA solution and were gently resuspended in complete DMEM.
Animals
C57BL/6 WT, PrxI-, and PrxII-deficient mice were used (Bae et al, 2011; Lee et al, 2003) .
Mice were performed on age-and gender-matched randomly assigned 8-to 12-week-old male mice conducted according to procedures approved by the Institutional Animal Care and Use Committee of the Yonsei Laboratory Animal Research Center (YLARC, 2015-0275) . Up to five mice per cage were housed in ventilated cages in a 12 hr light and 12 hr dark cycle.
Room temperature was at 22 o C, and they were fed with autoclaved standard rodent food and with drinking water at libitum.
Plasmids and in situ mutagenesis
Myc-or enhanced green fluorescent protein (EGFP)-tagged HMGB1 WT , HMGB1 C23S , and HMGB1 C45S were inserted into the pCMV-Myc plasmid for mammalian cell expression.
Myc/His-tagged human PrxI and PrxII plasmids were generated using the pCDNA3.1 vector. (Sobotta et al, 2015) , and subcloned into pcDNA TM 3.1/Myc-His. The HMGB1 NLS1/2A -GFP plasmid, a mutant plasmid wherein all the phosphorylation residues of six serines are changed to alanines in the NLS1 and 2 regions (Youn & Shin, 2006) , was subcloned into pCMV-Myc.
Cell culture, transfection, and reagents
Plasmid transfections were carried out using Fugene HD reagent or electroporation by
MicroPorator-mini. The histone deacetylase inhibitor TSA and PKC activator PMA for acetylation and phosphorylation, respectively, as well as H 2 O 2 and GOX from Aspergillus niger for oxidation were used. LPS (Escherichia coli 0111:B4, 49180) and TNF- were used for pro-inflammatory signaling. NAC was used as an antioxidant.
Measurement of HMGB1 secretion
To analyze the secretion of HMGB1 in the supernatants, culture media were replaced with serum-free OPTI-MEM medium and treated with various stimulants. The culture supernatants were harvested and concentrated via Amicon Centricon filtration after removing cell debris. Western blotting analysis was performed with rabbit anti-HMGB1 or mouse antiMyc antibodies as described below.
In vitro binding of PrxI/II proteins to HMGB1
HMGB1 and PrxI or PrxII proteins were reduced with 5 mM DTT for 1 hr and then the DTT was removed before the in vitro binding assay. A mixture of HMGB1 and PrxI or PrxII was exposed to 50 M H 2 O 2 with 0, 5, or 50 M DTT for 30 min to observe disulphide bond formation. The mixture was immunoprecipitated with mouse monoclonal anti-HMGB1 Ab and immunoblotted with rabbit polyclonal anti-PrxI, rabbit monoclonal anti-PrxII or rabbit polyclonal anti-HMGB1 antibodies after washing.
Confocal microscopy
Nucleocytoplasmic translocation of HMGB1 was observed under various stimulation conditions. HEK293T and HEK293T-TLR4 cells were transfected with EGFP-tagged HMGB1 WT , HMGB1 C23S , and HMGB1 C45S plasmids and cultured in a LabTekTM II chamber for 48 hr. Cells were treated with 5 mU/mL GOX, 50 μM H 2 O 2 , 250 nM PMA, 50 ng/mL TNF-, and 10 ng/mL TSA for 2 hr. HEK293T-TLR4 cells were treated with 1 g/mL LPS for 1 hr. Cells were fixed with 4% paraformaldehyde in PHEM buffer for 20 min at room temperature (RT) and washed with cold PBS. After mounting with 4',6'-diamidino-2-phenylindole, over 200 cells were observed to count the proportion of cytoplasmic HMGB1
(+) cells under confocal FV1000 microscopy (Olympus).
Proximity ligation assay (PLA)
The molecular interactions between HMGB1 and PrxI/II or CRM1 proteins were evaluated using a Duolink II Detection kit (Olink Bioscience). Briefly, HEK293T cells were cultured in eight well chambers (Nunc) and transfected with HMGB1 WT , HMGB1 C23S , or HMGB1
C45S
plasmids. Cells were fixed with 4% paraformaldehyde in PHEM buffer for 20 min at RT.
Cells were incubated with a blocking agent for 1 hr, and rabbit polyclonal anti-PrxI and antiPrxII were added and incubated overnight with either mouse monoclonal anti-HMGB1 or anti-myc for endogenous or exogenous HMGB1, respectively. Mouse monoclonal anti-CRM1 was incubated with rabbit polyclonal anti-HMGB1 to identify the HMGB1-CRM1 interaction. After three subsequent washes, PLA probes were applied and incubated for 1 hr in a humidity chamber at 37C. Unbound PLA probes were removed and the samples were incubated in the ligation solution for 1 hr. For amplification, polymerase was applied with fluorescently labeled oligonucleotides for 100 min at 37°C. The amplified fluorescencelabeled oligonucleotide was visible as a distinct fluorescent spot and images were taken by confocal microscopy.
Mouse study C57BL/6 WT, PrxI-and PrxII-deficient mice were used to investigate the effect of PrxI/II on HMGB1 secretion in vivo. Mice were intraperitoneally injected with 5 mg/kg LPS and then serum samples were collected at 1 and 16 hr for TNF- and HMGB1 measurements, respectively. Serum HMGB1 and TNF- were measured according to the manufacturer's protocols.
Western blot analysis and immunoprecipitation
HEK293T or MEF cells in six-well plates were transfected with plasmids using FuGene HD or electroporated using the MicroPorator-mini. Cells were washed with phosphate buffered saline (PBS) and lysed in 1× RIPA buffer containing 150 mM NaCl, 1% Triton X-100, 1%
deoxycholic acid sodium salt, 0.1% SDS, 50 mM Tris-HCl pH 7.5, 2 mM EDTA, and protease inhibitor cocktail. For thiol blocking, 50 mM NEM was added to inhibit the breakage or new disulphide bond formation. Whole cell lysates (WCLs) were centrifuged at 20,000 × g for 10 min at 4°C. Protein sample buffer (100 mM Tris-HCl pH 6.8, 2% SDS, 25% glycerol, 0.1% bromophenol blue, and 5% -mercaptoethanol) was added to the WCLs were washed three times with ice-cold PBS and then mixed with protein sample buffer followed by heating at 94°C for 5 min. The proteins were separated using SDS-PAGE.
Measurement of PrxI/II concentration
To determine the concentration of PrxI and PrxII proteins in the nucleus, nuclear fractionation was obtained using nuclear/cytosolic fractionation kit according to the manufactures'
procedure. Fifteen micrograms of each nuclear fraction were separated with known amounts of standard PrxI and II proteins from mouse liver lysate. The concentration of standard PrxI or II protein was previously identified by comparing the band intensities with those of recombinant PrxI and PrxII protein using SDS-PAGE. Anti-PrxI and anti-PrxII antibodies were used for western blot. PrxI and PrxII concentrations were calculated by comparing their band intensities with those of standard protein using Image J.
Nuclear/cytosolic fractionation
To determine the localization of the intracellular interaction between HMGB1 and PrxI or Cells were harvested by centrifugation at 600 × g for 5 min at 4°C. Nuclear/cytosolic fractionation was performed using a nuclear/cytosolic fractionation kit according to the manufacturer's procedure.
Statistical analysis
Analysis of experimental data was performed with the Student's t test using GraphPad Prism.
Data represent the mean value and SEM or SD, as indicated in the individual figure legends.
The difference was considered statistically significant when p < 0.05. were incubated in the absence or presence of 50 μM H 2 O 2 for 30 min, after which whole cell lysates were subjected to immunoprecipitation (IP) with antibodies to the His 6 tag and the resulting precipitates were subjected to immunoblot analysis with antibodies to the Myc tag.
Figure Legends
E. The whole cell lysates prepared in (C) and (D) were also separated into cytosolic and nuclear fractions before immunoprecipitation and immunoblot analysis. The fractions were also directly subjected to immunoblot analysis of Sp1 and GAPDH as marker proteins for the nucleus and cytosol, respectively. C. MEFs were stimulated with LPS (50 or 250 ng/ml) for 24 h, after which culture supernatants were harvested, mixed or not with DTT, and subjected to nonreducing SDS-PAGE followed by immunoblot analysis with antibodies to HMGB1.
D, E HEK293T cells expressing Myc-HMGB1(WT) or Myc-HMGB1(NLS1/2A) were incubated in the absence or presence of 10 mM NAC or 250 nM PMA for 24 h (D) or of 10 mM NAC or GOX (50 μU/ml) for 24 h (E). Culture supernatants were then harvested and subjected to immunoblot analysis with antibodies to Myc (upper panels). Relative Myc-HMGB1 band intensities were determined as means ± SEM from three independent experiments (lower panels). *P < 0.05, **P < 0.01 (Student's t test).
See also Expanded View figure 3. A. HEK239T cells transfected with expression vectors for CRM1 and Myc epitope-tagged WT, C23S, or C45S forms of HMGB1 were incubated in the absence or presence of 50 M H 2 O 2 or GOX (0.5 mU/ml) for 2 h, after which cell lysates were subjected to immunoprecipitation with antibodies to Myc. The resulting precipitates as well as the whole cell lysates (WCL) were subjected to immunoblot analysis with antibodies to CRM1 and to Myc.
B. HEK293T cells expressing Myc epitope-tagged WT, C23S, or C45S forms of HMGB1
were incubated in the absence or presence of 50 μM H 2 O 2 or GOX (5 mU/ml) for 2 h and then subjected to a PLA assay with antibodies to Myc and to CRM1. Scale bars, 10 m.
Figure 5. Deficiency of PrxI or PrxII attenuates HMGB1 secretion in BMDMs.
BMDMs derived from WT, PrxI-deficient (PrxI -/-), or PrxII-deficient (PrxII -/-) mice were incubated in the absence or presence of LPS (100 ng/ml) (A), 250 nM PMA (B), TSA (50 ng/ml) (C), or TNF (50 ng/ml) (D) for 24 h, after which culture supernatants were subjected to immunoblot analysis with antibodies to HMGB1 (upper panels). Relative HMGB1 band intensities (secretion levels) are presented as means ± SEM from three independent experiments (lower panels). The fold induction of secretion by each stimulus is also shown.
See also Expanded View figure 4. 
